An immunoassay is a chemical test used to detect or quantify a specific substance using an immunological reaction. Immunoassays are utilized in healthcare industry in diagnostics applications, such as infectious diseases, endocrinology, oncology, bone & mineral disorders, cardiology, hematology & blood screening, autoimmune disorders, neonatal screening, and in toxicology testing.
In 2019, the global immunoassays market was valued at $13.99 billion. This market is projected to reach $19.76 billion by 2025 growing at a CAGR of 5.9% during the forecast period of 2019 to 2025.
Here are the Top 10 Companies in Immunoassay :
Abbott Laboratories
Incorporated in 1888 and headquartered at Illinois, U.S., Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a range of healthcare products. The Company operates through four major segments namely, Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. Products related to immunoassays are provided by the Diagnostic Products segment. The Diagnostic Products segment is further divided into four segments namely, Core Laboratory, Rapid Diagnostics, Point of Care, and Molecular. It includes a range of diagnostic systems and tests manufactured, marketed, and sold around the world. These products are marketed and sold to blood banks, hospitals, commercial laboratories, clinics, physicians’ offices, government agencies, alternate care testing sites, and plasma protein therapeutic companies from its distribution centers, public warehouses, or third-party distributors.
The Company operates 94 manufacturing facilities globally, of which 23 are manufacturing sites for diagnostics products. The company has a global presence and sells its products in over 150 countries including Asia, Europe, Canada, South America, and the U.S. Some of the major subsidiaries of the company are Murex Diagnostics, Inc. (U.S.), Abbott Diagnostics International, Ltd. (Bermuda), Alere (Shanghai) Diagnostics Co., Ltd, Abbott Diagnostics GmbH (Germany), Standard Diagnostics, Inc. (Korea), Abbott Diagnostics Technologies AS (Norway), SPD Swiss Precision Diagnostics GmbH (Switzerland), and Alere, Inc. (U.S.).
F. Hoffmann-La Roche
Founded in 1896 and headquartered at Basel, Switzerland; F. Hoffmann-La Roche is a global research-based pharmaceuticals and diagnostics manufacturer. The company operates in the market through two main divisions namely, Pharmaceuticals and Diagnostics Division. The products related to immunoassays are provided by Diagnostics Division of the company. The Diagnostics Division is further segmented into four major divisions namely, Centralised and Point of Care Solutions, Molecular Diagnostics, Diabetes Care, and Tissue Diagnostics.
The company is active in over 100 countries and manufactures the diagnostics products in 20 production sites spread in 13 different countries. Some of the major subsidiaries of company are Roche Diagnostics (Switzerland), Ventana Medical Systems, Inc. (U.S.), Roche Diagnostics Corporation (U.S.), Roche Diagnostics Australia Pty Limited, Roche Diagnostics GmbH (Germany), Roche Diagnostics Korea Co., Ltd., and Roche Diagnostics India Pvt Ltd.
Siemens AG
Founded in 1847, Siemens is one of the leading electronics technology companies, globally. The company is headquartered at Munich, Germany and operates through eight major segments namely, Siemens Healthineers, Power and Gas, Digital Factory, Siemens Games, Renewable Energy, Energy Management, Mobility, Process Industries and Drives, and Building Technologies. The company‘s healthcare business is operated under its Siemens Healthineers business unit which mainly offers diagnostic imaging systems, ultrasound systems, point-of-care diagnostics solutions, laboratory diagnostics systems, and several other medical devices for advanced therapies.
The company is among the leading medical device manufacturers, globally and operates in more than 200 countries, either directly or through distributors. Some of the major subsidiaries of the company providing healthcare solutions are Siemens Healthcare Diagnostics GmbH (Germany), Siemens Healthcare Diagnostics Products GmbH (Germany), Siemens Healthcare Diagnostics Manufacturing Limited (Ireland), FAST TRACK DIAGNOSTICS LUXEMBOURG S.à r.l. (Luxembourg), Fast Track Diagnostics Ltd (Malta), and Siemens Diagnostics Holding II B.V. (the Netherlands).
Danaher Corporation
Incorporated in 1969 and headquartered at Washington, D.C, U.S., Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. Danaher operates through four major segments, namely, Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. The immunoassays product range is provided through the diagnostics segment of the company. The Company’s Diagnostics segment offers analytical instruments, reagents, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose diseases.
The company has facilities in over 60 countries, including approximately 261 significant office, research and development, manufacturing, and distribution facilities. Around 109 of these facilities are located in the U.S. in over 25 states and 152 are located outside the U.S. in over 30 other countries, primarily in Europe and to a lesser extent in Asia, South America, the rest of North America, and Australia. Some of the major subsidiaries of the company are Beckman Coulter (U.S.), Cepheid Inc. (U.S.), HemoCue (Sweden), Leica Biosystems (Germany), and Radiometer (Denmark).
Diasorin SPA
Founded in 1968, and headquartered at Saluggia, Italy; Diasorin is engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring, and autoimmunity. The company operates through two major segments namely, Immunodiagnostics and Molecular diagnostics.
The Company provides the diagnostics products through five major divisions, namely, CLIA Tests, Instrument Sales and Other Revenues, RIA & ELISA Tests, FOCUS, Molecular Tests. The Group headed by DiaSorin S.p.A. is made of 24 companies and 4 branches on the 5 continents; it produces its own tests at 7 manufacturing facilities located in Europe, Africa, and the U.S. DiaSorin distributes its test and platforms all over the world through its commercial subsidiaries, present in Europe, the United States, Mexico, Brazil, China, Australia, and Israel. In other countries, the Group operates through an international network of over 100 independent distributors. Some of the major subsidiaries of DiaSorin are DiaSorin Iberia S.A., Diasorin AB (Sweden), Diasorin Austria GmbH, Diasorin Switzerland AG, Diasorin Ltd. (China), Diasorin Ltd (U.K.), and Diasorin Diagnostics Ireland Limited.
A report into the projected growth of the current Immunoassay Market by Meticulous Research® has produced some incredible forecasts for the industry. By 2025, it’s expected to have grown at a CAGR of 5.9%, reaching over $ 19.76 billion.
Sysmex Corporation
Founded in 1968 and headquartered at Kobe, Hyōgo, Japan; Sysmex Corporation develop, manufacture, sales diagnostic instruments, reagents and related software. The Company caters to the national and other public hospitals, private hospitals, universities, research institutes, and other medical institutions. It operates through four reporting segments, namely, Reagents, Instruments, Service and Support, and Other. The Company provides immunoassays for hemostasis, flow cytometers, and other services.
Globally, Sysmex delivers total solutions in the field of clinical laboratory testing, including hematology, hemostasis, clinical chemistry, immunoassay system, flow cytometry and life science. The Company provides products and services to customers in more than 190 countries and majorly operates through their 75 facilities, globally. Some of the major subsidiaries of company are Sysmex International Reagents Co., Ltd. (Japan), Sysmex America, Inc., Sysmex Canada, Inc., Sysmex Europe GmbH (Germany), Sysmex UK Limited, Sysmex France S.A.S., Sysmex Espana S.L., Sysmex Shanghai Ltd., Sysmex Asia Pacific Pte Ltd. (Singapore), and Sysmex India Pvt. Ltd.
Biomerieux SA
Founded in 1963 and headquartered at Marcy-l’Étoile, France; Biomerieux SA specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company design, develop, manufactures, and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. The Company operates through five major segments, namely, Microbiology, Immunoassays, Molecular Biology, Industrial Application, and Other Lines. Products related to immunoassays market is provided by Immunoassays segment of the company.
BioMerieux SA operates through its numerous subsidiaries in various countries, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis (U.S), Biomerieux India Pvt. Ltd, and BioFire Diagnostics Inc. (U.S.)
QIAGEN
Headquartered at Venlo, Netherlands and founded in 1984, QIAGEN is the global provider of Sample to Insight solutions that enable customers to gain molecular insights from samples containing the building blocks of life. The Company‘s technologies isolate and process DNA, RNA and proteins from blood, tissue, and other materials. The Company also provides assay technologies, bioinformatics software, and knowledge bases that interpret data to report relevant, actionable insights. The Company operates through four major business units namely, Molecular Diagnostics, Academia, Pharma, and Applied Testing. Immunoassay products and solutions are provided by Molecular Diagnostics division of the company.
QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (primarily forensics), Pharma (pharma and biotech companies), and Academia (life sciences research). Some of the major subsidiaries of the company are Amnisure International, LLC. (U.S.), Cellestis Ltd. (Australia), QIAGEN AB (Sweden), QIAGEN AG (Switzerland), QIAGEN China Co. Ltd., QIAGEN Deutschland Holding GmbH (Germany), and QIAGEN France S.A.S.
Thermo Fisher Scientific
Incorporated in 1960 and headquartered at Massachusetts, U.S., Thermo Fisher Scientific develops, manufactures and sells a range of healthcare-related products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery, and diagnostics. The Company serves various markets, such as pharmaceutical and biotech; academic and government; industrial and applied; as well as healthcare and diagnostics. The Company operates through four major segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The products related to immunoassays are provided by Specialty Diagnostics Segment of the company.
Thermo Fisher has approximately 70,000 employees and serves more than 400,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental, industrial quality and process control settings. Some of the major subsidiaries of the company are Thermo Fisher Scientific C.V. (Netherlands), Thermo Fisher Scientific Oy (Finland), and Thermo Fisher Scientific (China) Holding Limited (U.K.).
Agilent Technologies, Inc.
Founded in 1999 and headquartered at California, U.S., Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. The Company has three business segments: Life Sciences and Applied Markets Business, Diagnostics and Genomics Business, and Agilent CrossLab Business. The products related to immunoassay market are provided by Diagnostics and Genomics Business. The Company’s diagnostics and genomics business segment consists of approximately three areas of activity providing solutions that include reagents, instruments, software and consumables, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. Its pathology solutions business is focused on product offerings to cancer diagnostics and anatomic pathology workflows.
The portfolio of offerings includes immunohistochemistry (IHC), In Situ Hybridization (ISH), Hematoxylin and Eosin (H&E), staining and special staining. Some of the major subsidiaries of the company are Agilent Technologies Luxco S.à.r.l., Agilent Technologies Europe B.V. (Netherlands), Agilent Technologies Singapore (Holdings) Pte. Ltd., and Agilent Technologies Rhone S.à.r.l. (Switzerland).
Authoritative Research on the Immunoassay Market – Global Opportunity Analysis and Industry Forecast (2019-2025)
Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:
- Recent financial performance
- Key products
- Significant company strategies
- Partnerships and acquisitions
The comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.
Please download report pages and learn more: